Rapilif-D 4 / 0.5 Capsule is a combination of medicine primarily used to treat the symptoms of benign prostatic hyperplasia (BPH) in adults with an enlarged prostate gland. It helps to relieve symptoms such as difficulty urinating or urge to urinate more often and improve your ability to urinate. The prostate is a small, muscular gland in the male reproductive system. Enlargement of the prostate is called BPH common condition as men get older (50-60 years). It occurs when the cells of the prostate gland begin to multiply. In an enlarged prostate gland, the bladder wall becomes thicker, and the bladder may weaken and lose the ability to empty fully, leaving some urine in the bladder.

Rapilif-D 4 / 0.5 Capsule is a combination of two drugs, namely; Silodosin and Dutasteride. Silodosin belongs to a class of alpha-1 receptors (located in prostate and bladder) blocker that works by blocking the action of alpha-1 receptors and causes smooth muscle relaxation in the bladder and prostate. Dutasteride belongs to a class of 5-alpha reductase that works by blocking the action of a 5-alpha reductase enzyme, resulting in a shrink of the size of the prostate gland. Rapilif-D 4 / 0.5 Capsule reduces the BPH symptoms and improves your ability to urinate.

Take Rapilif-D 4 / 0.5 Capsule as prescribed. Your doctor will recommend how often you take Rapilif-D 4 / 0.5 Capsule based on your medical condition. In some cases, you may experience certain common side effects such as dizziness, headache, nasal congestion (stuffy nose), and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

To treat your condition effectually continue taking Rapilif-D 4 / 0.5 Capsule for as long as your doctor has prescribed it. Try not to stop taking it on your own. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Rapilif-D 4 / 0.5 Capsule . Avoid consumption of alcohol as it may increase the side effects like dizziness and low blood pressure. If you take Rapilif-D 4 / 0.5 Capsule with any antihypertensive medicine, your blood pressure could suddenly drop to s life-threatening level. So avoid intake of Rapilif-D 4 / 0.5 Capsule with antihypertensive drugs.

Rapilif-D 4 / 0.5 Capsule is a combination of two drugs, namely; Silodosin and Dutasteride used to treat the symptoms of benign prostatic hyperplasia (BPH) in adults with an enlarged prostate gland. Silodosin belongs to a class of alpha-1 receptors (located in prostate and bladder) blocker that works by blocking the action of alpha-1 receptors and causes smooth muscle relaxation in the bladder and prostate. Dutasteride belongs to a class of 5-alpha reductase that works by blocking the action of a 5-alpha reductase enzyme, resulting in a shrink of the size of the prostate gland. Rapilif-D 4 / 0.5 Capsule reduces the BPH symptoms and improves your ability to urinate.

Do not take Rapilif-D 4 / 0.5 Capsule if you are allergic to Rapilif-D 4 / 0.5 Capsule and ingredients in it. Consult your doctor before taking Rapilif-D 4 / 0.5 Capsule if you are taking medicines for the treatment of hypertension (high blood pressure). If you take Rapilif-D 4 / 0.5 Capsule with any antihypertensive medicine your blood pressure could suddenly drop to a life-threatening level. So avoid intake of Rapilif-D 4 / 0.5 Capsule with antihypertensive drugs. Do not take Rapilif-D 4 / 0.5 Capsule if you have/had a heart attack or stroke or heart failure, low blood pressure, kidney or liver disease, have certain eye diseases, loss of vision due to loss of blood flow to the optic (eye) nerve. You are advised not to drive or operate heavy machinery after taking Rapilif-D 4 / 0.5 Capsule as it may cause dizziness. Avoid consuming alcohol along with Rapilif-D 4 / 0.5 Capsule as it could lead to increased dizziness and drowsiness. Older patients may be more sensitive to the side effects of Rapilif-D 4 / 0.5 Capsule , especially dizziness and low blood pressure when getting up from a sitting or lying position. Rapilif-D 4 / 0.5 Capsule should not be given to women and children less than 18 years of age.

• Regularly monitor blood pressure is required while taking Rapilif-D 4 / 0.5 Capsule .